BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9406720)

  • 1. Biodistribution of iodine-125 labeled monoclonal antibody/interleukin-2 immunoconjugate in athymic mice bearing human tumor xenografts.
    Nakamura K; Kubo A
    Cancer; 1997 Dec; 80(12 Suppl):2650-5. PubMed ID: 9406720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-2 on the biodistribution of technetium-99m-labelled anti-CEA monoclonal antibody in mice bearing human tumour xenografts.
    Nakamura K; Kubo A
    Eur J Nucl Med; 1994 Sep; 21(9):924-9. PubMed ID: 7995285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
    LeBerthon B; Khawli LA; Alauddin M; Miller GK; Charak BS; Mazumder A; Epstein AL
    Cancer Res; 1991 May; 51(10):2694-8. PubMed ID: 2021947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors.
    Khawli LA; Miller GK; Epstein AL
    Cancer; 1994 Feb; 73(3 Suppl):824-31. PubMed ID: 8306266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
    Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
    Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
    Buchsbaum DJ; ten Haken RK; Heidorn DB; Lawrence TS; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z; Lichter AS
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1033-41. PubMed ID: 2347713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants.
    Mariani G; Lasku A; Balza E; Gaggero B; Motta C; Di Luca L; Dorcaratto A; Viale GA; Neri D; Zardi L
    Cancer; 1997 Dec; 80(12 Suppl):2378-84. PubMed ID: 9406686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen.
    Starling JJ; Maciak RS; Hinson NA; Nichols CL; Briggs SL; Laguzza BC; Smith W; Corvalan JR
    Bioconjug Chem; 1992; 3(4):315-22. PubMed ID: 1382618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025.
    Hyams DM; Esteban JM; Lollo CP; Beatty BG; Beatty JD
    Arch Surg; 1987 Nov; 122(11):1333-7. PubMed ID: 3675197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
    Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a protein fragment of interleukin 2 responsible for vasopermeability.
    Epstein AL; Mizokami MM; Li J; Hu P; Khawli LA
    J Natl Cancer Inst; 2003 May; 95(10):741-9. PubMed ID: 12759392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pre-irradiation on radiopharmaceutical localization in human colon tumor xenografts using mono- and bispecific monoclonal antibodies.
    Gridley DS; Slater JB; Mackensen DG; Slater JM
    Anticancer Res; 1996; 16(6B):3453-8. PubMed ID: 9042206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.
    Maeda M; Shoji M; Kawagoshi T; Futatsuya R; Honda T; Brady LW
    Cancer; 1994 Feb; 73(3 Suppl):800-7. PubMed ID: 8306263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biodistribution of 791T/36 monoclonal antibody and its Fab/c fragment in BALB/c mice and nude mice bearing human tumor xenografts.
    Demignot S; Pimm MV; Baldwin RW
    Cancer Res; 1990 May; 50(10):2936-42. PubMed ID: 2334894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha-2b immunoconjugate for improving immunoscintigraphy and immunotherapy.
    Pallela VR; Rao SP; Thakur ML
    J Nucl Med; 2000 Jun; 41(6):1108-13. PubMed ID: 10855643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies.
    Esteban JM; Hyams DM; Beatty BG; Merchant B; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):989s-992s. PubMed ID: 2297752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
    Kennel SJ; Falcioni R; Wesley JW
    Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors.
    Hornick JL; Khawli LA; Hu P; Sharifi J; Khanna C; Epstein AL
    Clin Cancer Res; 1999 Jan; 5(1):51-60. PubMed ID: 9918202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.